Malissa Ha, MS, MB(ASCP)

Malissa Ha, MS, MB(ASCP) has diverse work experience in the healthcare and biotechnology industries. Malissa is currently working at Magnolia Medical Technologies as a Senior Business Director, where they focus on developing and marketing innovative blood collection devices to improve laboratory test accuracy and patient safety. Prior to this, they held the role of Business Director at the same company, where they contributed to the development of the flagship product, Steripath®, which reduces blood culture contamination and improves sepsis testing accuracy.

Before joining Magnolia Medical Technologies, Malissa worked at GenMark Diagnostics as a Sr. Molecular Account Executive, where they were responsible for account management and sales. Malissa also held the position of Molecular Applications Specialist and was involved in molecular diagnostic techniques and applications.

Earlier in their career, Malissa worked as a Molecular Technologist II at Thomas Jefferson University Hospital, where they gained expertise in molecular testing. Malissa also served as a Graduate Laboratory Teaching Associate at Thomas Jefferson University, where they developed educational labs and managed lab materials for the Biotechnology program.

Malissa's skills in research and analysis were honed during their time as a Student Research Assistant at the University of Medicine and Dentistry of New Jersey. Malissa conducted experiments investigating the role of the Nucleotide Binding Domain 1 of ABCA4 with retinoids and developed a putative model of retinal transport.

Additionally, Malissa has experience in a leadership role as a Supervisor at Easy Pickins, where they supervised a team of employees, managed daily operations, and implemented strategies to increase sales.

Overall, Malissa Ha brings a comprehensive background in business development, sales, laboratory testing, and research to their current role as a Senior Business Director at Magnolia Medical Technologies.

Malissa Ha, MS, MB(ASCP) has a strong educational background in the field of biotechnology and applied molecular technologies. Malissa obtained their Master's degree in Biotechnology/Applied Molecular Technologies from Jefferson Health in 2011. Prior to that, they completed their Bachelor's degree in Biotechnology from the same institution in 2010.

Malissa'searlier education includes studying Biology with a focus on Genetics and Developmental Biology at Penn State University from 2006 to 2008, although they did not obtain a degree during that period.

In addition to their academic achievements, Malissa Ha holds a certification as a Certified Molecular Technologist from the American Society for Clinical Pathology, which they obtained in May 2012.